Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nautilus Biotechnology, Inc. (NAUT) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nautilus Biotechnology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1808805.
Total stock buying since 2021: $8,279,510.
Total stock sales since 2021: $234,598.
Total stock option exercises since 2021: $38,734.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 105,733 | $98,290 | 0 | $0 | 0 | $0 |
| 2024 | 50,000 | $140,534 | 82,031 | $234,598 | 82,031 | $37,734 |
| 2022 | 453,000 | $1,188,584 | 0 | $0 | 100 | $1,000 |
| 2021 | 1,004,520 | $6,852,102 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 28,500 | $21,372 | 0 | $0 | 0 | $0 |
| 2025-03 | 77,233 | $76,918 | 0 | $0 | 0 | $0 |
| 2024-09 | 0 | $0 | 82,031 | $234,598 | 82,031 | $37,734 |
| 2024-03 | 50,000 | $140,534 | 0 | $0 | 0 | $0 |
| 2022-09 | 270,000 | $580,838 | 0 | $0 | 0 | $0 |
| 2022-08 | 77,500 | $214,721 | 0 | $0 | 0 | $0 |
| 2022-06 | 5,500 | $15,125 | 0 | $0 | 0 | $0 |
| 2022-05 | 50,000 | $198,000 | 0 | $0 | 0 | $0 |
| 2022-03 | 50,000 | $179,900 | 0 | $0 | 100 | $1,000 |
| 2021-12 | 318,022 | $1,622,532 | 0 | $0 | 0 | $0 |
| 2021-11 | 296,978 | $1,454,800 | 0 | $0 | 0 | $0 |
| 2021-08 | 59,470 | $457,768 | 0 | $0 | 0 | $0 |
| 2021-06 | 330,050 | $3,317,002 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-29 | Mowry Anna (CFO and Treasurer) | Buy | 15,000 | .77 | 11,490 |
| 2025-05-12 | Mallick Parag (Chief Scientist) | Buy | 1,500 | .73 | 1,098 |
| 2025-05-08 | Mallick Parag (Chief Scientist) | Buy | 12,000 | .73 | 8,784 |
| 2025-03-20 | Patel Sujal M (CEO, President, and Secretary) | Buy | 23,933 | 1.00 | 23,885 |
| 2025-03-19 | Patel Sujal M (CEO, President, and Secretary) | Buy | 53,300 | .99 | 53,033 |
| 2024-09-23 | Godwin Mary E. (Senior VP, Operations) | Sale | 47,031 | 2.87 | 134,743 |
| 2024-09-23 | Godwin Mary E. (Senior VP, Operations) | Option Ex | 47,031 | .46 | 21,634 |
| 2024-09-17 | Godwin Mary E. (Senior VP, Operations) | Sale | 35,000 | 2.85 | 99,855 |
| 2024-09-17 | Godwin Mary E. (Senior VP, Operations) | Option Ex | 35,000 | .46 | 16,100 |
| 2024-03-11 | Patel Sujal M (CEO, President, and Secretary) | Buy | 12,044 | 2.84 | 34,217 |
| 2024-03-08 | Patel Sujal M (CEO, President, and Secretary) | Buy | 2,430 | 2.99 | 7,263 |
| 2024-03-07 | Patel Sujal M (CEO, President, and Secretary) | Buy | 18,854 | 2.89 | 54,431 |
| 2024-03-06 | Patel Sujal M (CEO, President, and Secretary) | Buy | 9,267 | 2.70 | 25,030 |
| 2024-03-05 | Patel Sujal M (CEO, President, and Secretary) | Buy | 7,405 | 2.65 | 19,593 |
| 2022-09-27 | Sankar Subramanian (Senior VP, Product Development) | Buy | 5,000 | 2.03 | 10,149 |
| 2022-09-26 | Sankar Subramanian (Senior VP, Product Development) | Buy | 10,000 | 2.02 | 20,250 |
| 2022-09-23 | Weld Gwen E (Chief People Officer) | Buy | 30,000 | 2.03 | 60,779 |
| 2022-09-16 | Sankar Subramanian (Senior VP, Product Development) | Buy | 70,000 | 2.16 | 150,920 |
| 2022-09-15 | Sankar Subramanian (Senior VP, Product Development) | Buy | 80,000 | 2.19 | 175,520 |
| 2022-08-19 | Mowry Anna (CFO and Treasurer) | Buy | 17,500 | 2.30 | 40,215 |
| 2022-08-15 | Murphy Matthew B. (General Counsel) | Buy | 7,500 | 2.84 | 21,307 |
| 2022-08-12 | Murphy Matthew B. (General Counsel) | Buy | 2,500 | 2.85 | 7,125 |
| 2022-08-08 | Patel Sujal M (CEO, President, and Secretary) | Buy | 8,346 | 2.93 | 24,445 |
| 2022-08-05 | Patel Sujal M (CEO, President, and Secretary) | Buy | 41,654 | 2.92 | 121,629 |
| 2022-06-27 | Mowry Anna (CFO and Treasurer) | Buy | 5,500 | 2.75 | 15,125 |
| 2022-05-09 | Patel Sujal M (CEO, President, and Secretary) | Buy | 50,000 | 3.96 | 198,000 |
| 2022-03-04 | Patel Sujal M (CEO, President, and Secretary) | Option Ex | 100 | 10.00 | 1,000 |
| 2022-03-03 | Patel Sujal M (CEO, President, and Secretary) | Buy | 50,000 | 3.60 | 179,900 |
| 2021-12-08 | Edelman Joseph (10% Owner) | Buy | 200,000 | 5.36 | 1,072,000 |
| 2021-12-01 | Posard Matthew L. | Buy | 30,000 | 4.47 | 134,100 |
| 2021-12-01 | Patel Sujal M (CEO, President, and Secretary) | Buy | 88,022 | 4.73 | 416,432 |
| 2021-11-30 | Posard Matthew L. | Buy | 20,000 | 4.57 | 91,400 |
| 2021-11-30 | Patel Sujal M (CEO, President, and Secretary) | Buy | 161,978 | 4.72 | 764,860 |
| 2021-11-24 | Mowry Anna (CFO and Treasurer) | Buy | 15,000 | 4.58 | 68,640 |
| 2021-11-15 | Mcilwain Matthew S (Director) | Buy | 100,000 | 5.30 | 529,900 |
| 2021-08-26 | Mcilwain Matthew S (Director) | Buy | 11,709 | 7.71 | 90,311 |
| 2021-08-25 | Mcilwain Matthew S (Director) | Buy | 11,693 | 7.74 | 90,457 |
| 2021-08-24 | Mcilwain Matthew S (Director) | Buy | 13,568 | 7.68 | 104,270 |
| 2021-08-13 | Murphy Matthew B. (General Counsel) | Buy | 5,000 | 7.56 | 37,805 |
| 2021-08-12 | Mowry Anna (CFO and Treasurer) | Buy | 17,500 | 7.71 | 134,925 |
| 2021-06-03 | Edelman Joseph (Director) | Buy | 330,050 | 10.05 | 3,317,002 |
Insider trading activities including stock purchases, stock sales, and option exercises of NAUT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nautilus Biotechnology, Inc. (symbol NAUT, CIK number 1808805) see the Securities and Exchange Commission (SEC) website.